Is Cocamide DEA Safe? A Formulator's Complete Guide to CDEA in Shampoo and Skincare

Mar 17, 2026

Leave a message

📋 In This Article

  1. What Is Cocamide DEA?
  2. Why Is Cocamide DEA Questioned?
  3. The Nitrosamine Issue: What the Science Actually Says
  4. Global Regulatory Status
  5. Skin Safety: Irritation, Sensitization, and Everyday Use
  6. Is Cocamide DEA Safe in Shampoo?
  7. Formulator Guidance: Minimizing Risk When Using CDEA
  8. When to Switch: DEA-Free Alternatives
  9. Sourcing Low-Risk Cocamide DEA
  10. FAQ
  11. Contact Sinolook Chemical

⚡ Quick Verdict

Generally safe at ≤5% in well-formulated rinse-off products with correct preservative selection

⚠️

Risk exists if combined with nitrosating agents or used in high-free-DEA grades

🚫

Restricted in EU cosmetics and listed as a carcinogen under California Prop 65

💡

Alternatives exist - Cocamide MEA is the standard DEA-free replacement for most systems

🥥 1. What Is Cocamide DEA?

Cocamide DEA - also written as Cocamide Diethanolamine, or abbreviated CDEA - is a non-ionic surfactant produced by reacting coconut oil fatty acids (predominantly lauric acid, C12) with diethanolamine (DEA). The result is a viscous amber liquid with the INCI name "Cocamide DEA" and CAS number 68603-42-9.

In personal care formulations, Cocamide DEA serves three main functions:

  • 🫧 Foam booster - enhances lather volume and creaminess when combined with primary anionic surfactants like SLES
  • 🌊 Viscosity builder - enables the classic salt-thickening method to reach target viscosity in shampoos and body washes
  • 🌿 Mild conditioner - reduces the harshness of anionic surfactant systems, leaving hair and skin feeling softer

It is one of the most commonly used cosmetic ingredients globally - a 2022 survey of personal care product databases found Cocamide DEA present in over 3,500 distinct product formulations across shampoo, body wash, hand soap, and bubble bath categories. Its widespread use is a direct result of its effectiveness and low cost relative to alternatives.

🔍 2. Why Is Cocamide DEA Questioned?

The safety debate around Cocamide DEA centers on a single core issue: its potential to form nitrosamines - specifically N-nitrosodiethanolamine (NDELA) - when the residual free DEA in the product reacts with nitrosating agents under the right conditions.

The sequence of events that raises concern is:

Free DEA
residual in CDEA
+
Nitrosating agent
e.g. bronopol, NO₂
NDELA
N-nitrosodiethanolamine
Carcinogen concern
IARC Group 2B

This reaction is accelerated by low pH (<6.5) and is not unique to Cocamide DEA - it applies to any secondary amine-containing cosmetic ingredient.

Critically, the concern is not with Cocamide DEA the molecule itself - CDEA is not classified as carcinogenic. The concern is with NDELA, the reaction product that can form if formulation conditions allow it. This distinction matters enormously for understanding the regulatory picture and for making rational formulation decisions.

💡 Key Distinction

Cocamide DEA itself is not classified as a carcinogen by IARC, the EU SCCS, or the US NTP. The hazard classification that appears on EWG and in Prop 65 databases refers to the potential to generate NDELA - a secondary reaction product - under adverse formulation conditions. In a properly formulated product, that reaction is prevented or minimized to safe levels.

🔬 3. The Nitrosamine Issue: What the Science Actually Says

3.1 What Is NDELA?

N-Nitrosodiethanolamine (NDELA, CAS 1116-54-7) is a volatile nitrosamine formed when free diethanolamine reacts with a nitrous acid source under mildly acidic conditions. IARC classifies NDELA as Group 2B - "possibly carcinogenic to humans" - based on animal studies showing carcinogenicity at high doses. Human epidemiological evidence is limited and inconclusive at the trace levels found in cosmetic products.

3.2 Three Conditions Required for NDELA Formation

All three of the following conditions must be simultaneously present for meaningful NDELA formation in a cosmetic product:

Free DEA present in the product

Residual unreacted diethanolamine from the CDEA synthesis process. High-quality CDEA with low free DEA (<1%) dramatically reduces this risk. Low-grade material can contain 3–5% free DEA.

A nitrosating agent in the formulation

Sources include: bronopol (2-bromo-2-nitropropane-1,3-diol), sodium nitrite, formaldehyde-releasing preservatives (DMDM hydantoin, diazolidinyl urea), nitrogen oxides from air, or certain ammonium compounds. Inert preservatives like phenoxyethanol are not nitrosating agents.

Mildly acidic pH (<6.5)

N-nitrosation of secondary amines is acid-catalyzed. At pH 6.5–7.5, the reaction rate is much slower. Most shampoos are formulated at pH 5.5–6.5 for scalp and cuticle compatibility - this is the pH range where the reaction is most relevant.

3.3 What Actual Levels Have Been Found in Products?

Regulatory surveillance studies conducted by the EU, FDA, and Health Canada have found NDELA in cosmetic products at levels typically ranging from undetectable to ~100 ppb (parts per billion) in well-formulated products, and up to several thousand ppb in poorly formulated or aged products with high free DEA content. The EU sets a guideline limit of 50 ppb NDELA for finished cosmetic products. For context, NDELA is also found naturally in some cooked foods (cured meats, malt beverages) at comparable or higher levels.

The scientific consensus - reflected in assessments by the EU SCCS, the US CIR Expert Panel, and Health Canada - is that Cocamide DEA poses no significant carcinogenic risk to consumers when used at appropriate concentrations in properly formulated products that avoid nitrosating co-ingredients. The risk is real but manageable through good formulation practice and raw material quality control.

📋 4. Global Regulatory Status

Jurisdiction Status Key Requirement / Limit
🇪🇺 EU (EC 1223/2009, Annex III) ⚠️ Restricted Max 5.0% in finished product; cannot be used with nitrosating agents; minimum purity requirements on raw material; NDELA limit ≤50 ppb in finished product
🇺🇸 USA - California (Prop 65) 🚫 Listed Carcinogen Listed since June 2012 as "known to the State of California to cause cancer." Products above the safe harbor level (currently 0.001 mg/day exposure) require Prop 65 warning label
🇺🇸 USA - Federal (FDA / CIR) ⚠️ Conditionally safe CIR: safe at ≤10% if formulated to prevent nitrosamine formation. FDA does not restrict but issued guidance in 1997 recommending manufacturers avoid combining DEA with nitrosating agents
🇨🇳 China (GB/T standards) ✅ Permitted Permitted in cosmetics; GB/T 26396 specifies nitrosamine limits in cosmetic products (NDELA ≤50 μg/kg). No specific concentration restriction on CDEA itself
🇨🇦 Canada (Health Canada) ⚠️ Monitored Health Canada conducts periodic surveillance for nitrosamines in cosmetics. CDEA is permitted; products with detectable NDELA above 50 ppb have been subject to corrective action
🌍 ASEAN / Middle East / LatAm ✅ Generally permitted Most markets follow EU positive-list approach or have no specific CDEA restriction. Some GCC countries reference EU Cosmetics Regulation by adoption
🌿 COSMOS / NATRUE / Clean Beauty 🚫 Excluded COSMOS-standard and NATRUE exclude all DEA-derived ingredients. Most consumer-facing "clean beauty" programs (Sephora Clean, Credo) explicitly prohibit DEA and all its derivatives

💡 What the California Prop 65 Listing Actually Means

California listed Cocamide DEA as a carcinogen in 2012 based on IARC's Group 2B classification of NDELA and a conservative regulatory approach that lists any substance with significant potential to generate a listed carcinogen. This does not mean every product containing Cocamide DEA is dangerous - it means that manufacturers selling into California must either ensure consumer exposure to NDELA remains below the safe harbor level, or affix a warning label. Most companies selling nationally have reformulated to avoid the labeling requirement.

🌸 5. Skin Safety: Irritation, Sensitization, and Everyday Use

5.1 Skin Irritation

At formulated concentrations in finished products (typically 1–5%), Cocamide DEA is non-irritating to normal healthy skin. The CIR Expert Panel reviewed extensive human and animal skin irritation data and concluded that Cocamide DEA is not a primary skin irritant at concentrations used in cosmetic formulations. This is consistent with its long history of use in mass-market shampoos used daily by billions of people worldwide without significant irritation reports.

The situation is different with undiluted material: neat Cocamide DEA (100% concentration) is a mild to moderate irritant, as are most surfactants and amide compounds at full strength. This is a handling concern for manufacturing personnel - not a consumer safety concern in finished products.

5.2 Skin Sensitization

Cocamide DEA is not considered a skin sensitizer (contact allergen) at typical cosmetic use levels. Repeated insult patch testing (RIPT) studies conducted for CIR review showed no sensitization reactions in human volunteers at concentrations up to 10% in rinse-off products and 5% in leave-on products. Occasional reports of DEA-related allergy in the literature typically involve occupational exposure to undiluted material or high-concentration industrial formulations - a different risk profile from consumer cosmetic use.

5.3 Is Cocamide DEA Safe for Sensitive Skin?

For consumers with declared sensitive skin, eczema, or compromised skin barrier, any surfactant-containing product warrants caution - not because of DEA specifically, but because anionic surfactants in general can disrupt the lipid barrier. Cocamide DEA itself does not carry extra sensitization risk for sensitive skin compared to the base surfactants in the formulation. However, for products specifically positioned for sensitive skin or babies, many brands proactively choose Cocamide MEA or DEA-free alternatives purely for consumer communication clarity.

Safety Endpoint Assessment Applicable Concentration
Primary skin irritation ✅ Non-irritating 1–10% in finished product
Skin sensitization / allergy ✅ Not a sensitizer At cosmetic use levels
Eye irritation ⚠️ Mild at >5% Rinse-off products generally safe
Nitrosamine (NDELA) formation ⚠️ Conditional risk Requires free DEA + nitrosating agent
Systemic absorption ✅ Low in rinse-off Rinse-off products have minimal dermal absorption
Reproductive / developmental toxicity ✅ No evidence at use levels No reproductive toxicity at cosmetic concentrations

🚿 6. Is Cocamide DEA Safe in Shampoo?

Shampoo is the highest-volume application for Cocamide DEA, and it is also the application that prompts the most consumer questions. The short answer: yes, Cocamide DEA is safe in shampoo when the formulation is properly designed - but the answer deserves unpacking.

6.1 Rinse-Off vs Leave-On: Why It Matters

Shampoo is a rinse-off product - it is applied to wet hair, worked into a lather for 30–60 seconds, and thoroughly rinsed away. This short contact time and complete removal substantially limits both dermal absorption and cumulative exposure to any ingredient, including any trace NDELA that might be present. The risk profile of Cocamide DEA in a rinse-off shampoo is fundamentally lower than in a leave-on product such as a hair serum or body lotion.

6.2 Scalp Exposure and Hair Safety

The scalp is one of the more permeable skin sites on the body, which means ingredient absorption during shampooing is not zero - but the short contact time and complete rinse substantially mitigate this. Multiple safety assessments, including the EU SCCS opinion on nitrosamines in cosmetics (SCCS/1294/10), have concluded that consumer exposure to NDELA from properly formulated shampoos is not a significant health risk, even accounting for daily use over a lifetime.

For hair itself, Cocamide DEA has no adverse effects - it does not damage the cuticle, affect color-treated hair adversely, or cause fragility. Its mild conditioning effect is beneficial for post-wash hair manageability.

6.3 Baby Shampoo and Children's Products

⚠️ Recommendation for Children's Products

For baby shampoos, children's bath products, and products specifically marketed for infants, most regulatory bodies - including the EU SCCS - recommend a conservative approach: avoid Cocamide DEA and use DEA-free alternatives. Children's skin is thinner and more permeable than adult skin, and the precautionary principle supports using the lowest-risk ingredients in products for this age group. This is a brand risk management recommendation as much as a toxicology-driven one.

🧪 7. Formulator Guidance: Minimizing Risk When Using CDEA

For formulators who need to use Cocamide DEA - whether for cost, performance, or market reasons - the following practices will minimize nitrosamine formation risk and bring the product into compliance with major regulatory frameworks:

① Specify low free-DEA raw material

Require free DEA content ≤1.0% on your incoming CoA. Standard commercial CDEA typically contains 1–3% free DEA; low-DEA grades available from quality suppliers contain <1%. This single step has the largest impact on NDELA formation potential.

② Exclude nitrosating preservatives

Never use bronopol, DMDM hydantoin, diazolidinyl urea, imidazolidinyl urea, or sodium nitrite in any formulation containing Cocamide DEA. Safe preservative alternatives: phenoxyethanol (±ethylhexylglycerin), sodium benzoate + potassium sorbate, caprylyl glycol, or parabens (where permitted).

③ Maintain formulation pH above 6.0

N-nitrosation is significantly slower at pH >6.5. Formulate shampoos to pH 6.0–7.0 and verify pH stability over 12 months under accelerated stability conditions. Avoid aggressive acidification with citric acid that pushes pH below 5.5.

④ Test finished product for NDELA

For EU market supply, test each batch for NDELA using GC-MS or GC-TEA at a certified laboratory. Target: ≤50 ppb. Include NDELA testing in your annual stability program - levels can rise over shelf life if storage conditions are poor.

⑤ Keep use level at or below 5%

EU Annex III restricts Cocamide DEA to 5% maximum. From a formulation standpoint, 2–3% is typically sufficient for viscosity and foam boosting in SLES systems - there is no functional reason to exceed 5%, and doing so only increases the nitrosamine risk surface.

🔄 8. When to Switch: DEA-Free Alternatives

If your market, brand positioning, or formulation system makes Cocamide DEA unsuitable, the following alternatives are available - each with different performance trade-offs:

Alternative Key Benefit vs CDEA Trade-off Best For
Cocamide MEA No nitrosamine risk; better conditioning; EU/EWG accepted Solid state - needs hot processing; less effective in salt thickening Most applications; EU/CA market primary alternative
Cocamide MIPA Liquid at room temperature; lower nitrosamine risk than DEA Less common; fewer second-source suppliers When liquid processability of DEA needed but DEA restricted
PEG-7 Glyceryl Cocoate Clean label; mild; COSMOS-compatible Weaker foam boost; less effective viscosity building Natural / COSMOS-certified shampoos
Lauryl Glucoside / Decyl Glucoside Fully plant-derived; mild; biodegradable Limited viscosity building; higher cost Baby care, sensitive skin, COSMOS formulations
Hydroxypropyl Starch Phosphate Amine-free thickener; clean label No foam benefit; different viscosity mechanism When viscosity building is the primary need

📦 9. Sourcing Low-Risk Cocamide DEA

When sourcing Cocamide DEA, the single most important quality parameter from a safety standpoint is free DEA content. This is the precursor that enables nitrosamine formation - not the amide itself. A reliable supplier will provide free DEA data on every batch CoA.

✅ Minimum Supplier Requirements for EU-Compliant CDEA

  • ✅ Free DEA content reported on CoA - target ≤1.0%
  • ✅ NDELA test result available on request (GC-TEA or GC-MS method)
  • ✅ REACH registration for EU supply (EINECS 271-657-0)
  • ✅ ISO 9001 quality management system
  • ✅ Batch-traceable CoA with active content, colour, pH, and moisture
  • ✅ Vegetable (coconut / palm kernel) feedstock confirmed and traceable
  • ✅ Sample available for incoming QC verification

❓ 10. Frequently Asked Questions

Q: Is Cocamide DEA a carcinogen?
Cocamide DEA itself is not classified as a carcinogen by IARC, the EU SCCS, or the US National Toxicology Program. What is classified as a possible carcinogen (IARC Group 2B) is NDELA - a nitrosamine that can form when the residual free DEA in CDEA reacts with a nitrosating agent under acidic conditions. California's Prop 65 listing applies to Cocamide DEA as a substance that can generate NDELA under certain conditions - not because CDEA itself is carcinogenic. In properly formulated products that prevent nitrosamine formation, the carcinogenic risk is not significant.
Q: Is Cocamide DEA safe for skin?
Yes, at concentrations used in cosmetic formulations (1–5%), Cocamide DEA is not a skin irritant or sensitizer. The CIR Expert Panel reviewed extensive dermatological data and concluded it is safe as used in cosmetic products. The safety caveat relates to nitrosamine formation - not to direct skin toxicity of the ingredient itself.
Q: Why is Cocamide DEA bad according to EWG?
EWG (Environmental Working Group) assigns Cocamide DEA a hazard score of 5–7 (moderate to high hazard) primarily due to its California Prop 65 listing and its potential to form NDELA. EWG's scoring methodology is precautionary and weights regulatory listings heavily - it does not represent a toxicological risk assessment at specific exposure levels. The EWG score reflects the existence of a hazard under specific conditions, not an assessment of actual consumer risk from properly formulated products. For brands targeting EWG Verified status or clean beauty markets, the score represents a commercial obstacle regardless of actual safety.
Q: What are the side effects of Cocamide DEA on hair?
There are no known adverse effects of Cocamide DEA on hair structure, color, or health at concentrations used in shampoo formulations. It does not cause hair loss, color fading, protein damage, or increased breakage. Its effect on hair is mildly positive - it reduces friction between fibers during washing and provides a small conditioning contribution that improves post-wash manageability. Reports of hair or scalp issues attributed to Cocamide DEA in shampoo typically reflect the action of the primary anionic surfactants in the formula (particularly SLES at high concentrations) rather than the alkanolamide itself.
Q: Does Cocamide DEA cause cancer?
There is no epidemiological evidence that consumer use of Cocamide DEA-containing shampoos or cosmetics causes cancer in humans. The carcinogen concern relates to NDELA, a potential reaction product, not to Cocamide DEA directly. Animal studies showing carcinogenicity used NDELA at high doses administered directly - exposure scenarios that bear no resemblance to washing your hair with a diluted shampoo. Major regulatory bodies including the EU SCCS have reviewed all available evidence and found no basis to conclude that properly formulated Cocamide DEA cosmetics pose a cancer risk to consumers.
Q: What preservatives are safe to use with Cocamide DEA?
Safe preservatives for use with Cocamide DEA (non-nitrosating) include: phenoxyethanol (alone or with ethylhexylglycerin or caprylyl glycol), sodium benzoate + potassium sorbate blend, parabens (methylparaben, ethylparaben, propylparaben - where permitted), and benzyl alcohol. Avoid: bronopol, DMDM hydantoin, diazolidinyl urea, imidazolidinyl urea, quaternium-15, and sodium nitrite. When in doubt, ask your preservative supplier for their nitrosating potential classification.

📦 Source Low-Free-DEA Cocamide DEA from Sinolook Chemical

Sinolook Chemical supplies Cocamide DEA in standard and low-free-DEA grades, with full documentation including batch CoA (with free DEA data), NDELA test reports on request, MSDS, REACH registration, and HS code declarations. Minimum order 200 kg; sample quantities available for formulation trials and incoming QC verification.

💬 WhatsApp

+86 181 5036 2095

📱 WeChat / Tel

+86 134 0071 5622

🌐 Website

www.sinolookchem.com

🔗 Related Products & Reading: Cocamide DEA Product Page · SPAN 80 · PEG Oleate · Oleate Esters Category

Send Inquiry